Completed OBSERVATIONAL NCT03177343

Pristinamycin in the Treatment of MSSA Bone and Joint Infection

Sponsor: Hospices Civils de Lyon

Conditions Bone and Joint Infection Methicillin Susceptible Staphylococcus Aureus (MSSA) Infection

Updated 6 times since 2017 Last updated: Jun 2, 2017 Started: Feb 28, 2015 Primary completion: Aug 31, 2015 Completion: Aug 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Bone and Joint Infection and Methicillin Susceptible Staphylococcus Aureus (MSSA) Infection, this trial is completed. The trial is conducted by Hospices Civils de Lyon and has accumulated 6 data snapshots since 2015. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jul 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Feb 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospices Civils de Lyon

Data source: Hospices Civils de Lyon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lyon, France